These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25275044)
1. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma. Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044 [TBL] [Abstract][Full Text] [Related]
2. Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer. Chang WS; Liao CH; Hsu CM; Huang CY; Fang HY; Kao PY; Tsai CW; Wu HC; Hu PS; Wang TC; Syu YR; Shui HA; Bau DT Anticancer Res; 2015 May; 35(5):2725-30. PubMed ID: 25964551 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan. Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279 [TBL] [Abstract][Full Text] [Related]
4. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [TBL] [Abstract][Full Text] [Related]
5. The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma. Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Ji HX; Hsiao CL; Bau DT Anticancer Res; 2016 May; 36(5):2205-9. PubMed ID: 27127124 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089 [TBL] [Abstract][Full Text] [Related]
7. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes. Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432 [TBL] [Abstract][Full Text] [Related]
8. The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma. Chang WS; Ke HL; Tsai CW; Lien CS; Liao WL; Lin HH; Lee MH; Wu HC; Chang CH; Chen CC; Lee HZ; Bau DT Anticancer Res; 2012 Sep; 32(9):3855-60. PubMed ID: 22993329 [TBL] [Abstract][Full Text] [Related]
9. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153 [TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492 [TBL] [Abstract][Full Text] [Related]
11. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan. Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Tanaka Y; Hirata H; Chen Z; Kikuno N; Kawamoto K; Majid S; Tokizane T; Urakami S; Shiina H; Nakajima K; Dhir R; Dahiya R Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):92-7. PubMed ID: 17220335 [TBL] [Abstract][Full Text] [Related]
13. Association study of cyclooxygenase 2 single nucleotide polymorphisms and childhood acute lymphoblastic leukemia in Taiwan. Wang CH; Wu KH; Yang YL; Peng CT; Wang RF; Tsai CW; Tsai RY; Lin DT; Tsai FJ; Bau DT Anticancer Res; 2010 Sep; 30(9):3649-53. PubMed ID: 20944149 [TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men. Safarinejad MR; Shafiei N; Safarinejad S Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764 [TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenase 2 genetic variant interacting with tobacco smoking and the risk of lung cancer]. Zhang Z; Liu R; Yang ZH; Wang GX; Shao SS; Song QQ; Zhang XM Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):736-40. PubMed ID: 24246081 [TBL] [Abstract][Full Text] [Related]
16. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis. de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206 [TBL] [Abstract][Full Text] [Related]
17. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726 [TBL] [Abstract][Full Text] [Related]
18. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma. Huang Z; Lu Z; Tian J; Wang G; Gao Z Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945 [TBL] [Abstract][Full Text] [Related]
19. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma. Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440 [TBL] [Abstract][Full Text] [Related]
20. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations. Li M; Gao Y; Li C; Liu L; Li K; Gao L; Wang G; Zhang Z; Gao T J Dermatol Sci; 2009 Mar; 53(3):176-81. PubMed ID: 19004621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]